{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T15:08:40Z","timestamp":1765724920170,"version":"3.48.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,14]]},"DOI":"10.7759\/cureus.99187","type":"journal-article","created":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T15:04:21Z","timestamp":1765724661000},"source":"Crossref","is-referenced-by-count":0,"title":["Balancing Bleeding and Ischemic Risks: A Systematic Review of Dual Versus Triple Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation"],"prefix":"10.7759","author":[{"given":"Abubakar","family":"Gapizov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivam","family":"Singla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavna","family":"Singla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saifullah","family":"Syed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunita","family":"Kumawat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zulqurnain","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euad226","article-title":"Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal","volume":"25","author":"Lip GY","year":"2023","unstructured":"Lip GY, Proietti M, Potpara T, et al.. Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal. Europace. 2023, 25:10.1093\/europace\/euad226","journal-title":"Europace"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-021-01928-4","article-title":"Characteristics and antithrombotic treatment patterns of patients with concomitant coronary artery disease and atrial fibrillation from Thailand's COOL-AF registry","volume":"21","author":"Winijkul A","year":"2021","unstructured":"Winijkul A, Kaewkumdee P, Yindeengam A, Krittayaphong R. Characteristics and antithrombotic treatment patterns of patients with concomitant coronary artery disease and atrial fibrillation from Thailand's COOL-AF registry. BMC Cardiovasc Disord. 2021, 21:117. 10.1186\/s12872-021-01928-4","journal-title":"BMC Cardiovasc Disord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S391400","article-title":"Personalized approaches to antiplatelet treatment for cardiovascular diseases: an umbrella review","volume":"16","author":"Oliva A","year":"2023","unstructured":"Oliva A, Cao D, Spirito A, et al.. Personalized approaches to antiplatelet treatment for cardiovascular diseases: an umbrella review. Pharmgenomics Pers Med. 2023, 16:973-90. 10.2147\/PGPM.S391400","journal-title":"Pharmgenomics Pers Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5114\/amsad\/161172","article-title":"Dual antiplatelet therapy with concomitant anticoagulation: current perspectives on triple therapy","volume":"8","author":"Patail H","year":"2023","unstructured":"Patail H, Sharma T, Bali AD, Isath A, Aronow WS, Haidry SA. Dual antiplatelet therapy with concomitant anticoagulation: current perspectives on triple therapy. Arch Med Sci Atheroscler Dis. 2023, 8:e13-8. 10.5114\/amsad\/161172","journal-title":"Arch Med Sci Atheroscler Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-025-05838-4","article-title":"Efficacy, safety, and bleeding risk factor analysis of oral anticoagulants in AF patients\u2009\u2265\u200965 years of age: a multicenter retrospective cohort study","volume":"25","author":"Lan Y","year":"2025","unstructured":"Lan Y, Chen J, Niu P, et al.. Efficacy, safety, and bleeding risk factor analysis of oral anticoagulants in AF patients\u2009\u2265\u200965 years of age: a multicenter retrospective cohort study. BMC Geriatr. 2025, 25:203. 10.1186\/s12877-025-05838-4","journal-title":"BMC Geriatr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/clc.23224","article-title":"Vitamin K antagonist vs direct oral anticoagulants with antiplatelet therapy in dual or triple therapy after percutaneous coronary intervention or acute coronary syndrome in atrial fibrillation: meta-analysis of randomized controlled trials","volume":"42","author":"Roule V","year":"2019","unstructured":"Roule V, Ardouin P, Briet C, et al.. Vitamin K antagonist vs direct oral anticoagulants with antiplatelet therapy in dual or triple therapy after percutaneous coronary intervention or acute coronary syndrome in atrial fibrillation: meta-analysis of randomized controlled trials. Clin Cardiol. 2019, 42:839-46. 10.1002\/clc.23224","journal-title":"Clin Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd9120414","article-title":"Clinical and safety outcomes associated with extended treatment of venous thromboembolism: a network meta-analysis","volume":"9","author":"Liu Z","year":"2022","unstructured":"Liu Z, Tan J, Deng Y, Hua L, Guo T. Clinical and safety outcomes associated with extended treatment of venous thromboembolism: a network meta-analysis. J Cardiovasc Dev Dis. 2022, 9:10.3390\/jcdd9120414","journal-title":"J Cardiovasc Dev Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/1524839919893361","article-title":"A review of the PubMed PICO tool: using evidence-based practice in health education","volume":"21","author":"Brown D","year":"2020","unstructured":"Brown D. A review of the PubMed PICO tool: using evidence-based practice in health education. Health Promot Pract. 2020, 21:496-8. 10.1177\/1524839919893361","journal-title":"Health Promot Pract"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:l4898. 10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.118.007124","article-title":"Association of international normalized ratio stability and bleeding outcomes among atrial fibrillation patients undergoing percutaneous coronary intervention","volume":"12","author":"Kerneis M","year":"2019","unstructured":"Kerneis M, Yee MK, Mehran R, et al.. Association of international normalized ratio stability and bleeding outcomes among atrial fibrillation patients undergoing percutaneous coronary intervention. Circ Cardiovasc Interv. 2019, 12:e007124. 10.1161\/CIRCINTERVENTIONS.118.007124","journal-title":"Circ Cardiovasc Interv"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708454","article-title":"Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation","volume":"377","author":"Cannon CP","year":"2017","unstructured":"Cannon CP, Bhatt DL, Oldgren J, et al.. Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med. 2017, 377:1513-24. 10.1056\/NEJMoa1708454","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-19-00920","article-title":"Short-duration triple antithrombotic therapy for atrial fibrillation patients who require coronary stenting: results of the SAFE-A study","volume":"16","author":"Hoshi T","year":"2020","unstructured":"Hoshi T, Sato A, Hiraya D, et al.. Short-duration triple antithrombotic therapy for atrial fibrillation patients who require coronary stenting: results of the SAFE-A study. EuroIntervention. 2020, 16:e164-72. 10.4244\/EIJ-D-19-00920","journal-title":"EuroIntervention"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2021.106365","article-title":"Efficacy and safety of rivaroxaban and ticagrelor in elderly patients with atrial fibrillation undergoing percutaneous coronary intervention","volume":"104","author":"Liu X","year":"2021","unstructured":"Liu X, Wang L, Zhou M, Feng L. Efficacy and safety of rivaroxaban and ticagrelor in elderly patients with atrial fibrillation undergoing percutaneous coronary intervention. Contemp Clin Trials. 2021, 104:106365. 10.1016\/j.cct.2021.106365","journal-title":"Contemp Clin Trials"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks G","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, et al.. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021, 42:373-498. 10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.01.011","article-title":"2019 AHA\/ACC\/HRS Focused Update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"74","author":"January CT","year":"2019","unstructured":"January CT, Wann LS, Calkins H, et al.. 2019 AHA\/ACC\/HRS Focused Update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019, 74:104-32. 10.1016\/j.jacc.2019.01.011","journal-title":"J Am Coll Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-025-04908-0","article-title":"Comparative efficacy and safety of anticoagulant therapies in coronary artery disease: a network meta-analysis of randomized controlled trials","volume":"25","author":"Cui H","year":"2025","unstructured":"Cui H, Wang A, Zhong G. Comparative efficacy and safety of anticoagulant therapies in coronary artery disease: a network meta-analysis of randomized controlled trials. BMC Cardiovasc Disord. 2025, 25:456. 10.1186\/s12872-025-04908-0","journal-title":"BMC Cardiovasc Disord"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2015.08.010","article-title":"Practice variation in triple therapy for patients with both atrial fibrillation and coronary artery disease: insights from the ACC\u2019s national cardiovascular data registry","volume":"2","author":"Wasfy JH","year":"2016","unstructured":"Wasfy JH, Kennedy KF, Chen JS, Ferris TG, Maddox TM, Yeh RW. Practice variation in triple therapy for patients with both atrial fibrillation and coronary artery disease: insights from the ACC\u2019s national cardiovascular data registry. JACC Clin Electrophysiol. 2016, 2:36-43. 10.1016\/j.jacep.2015.08.010","journal-title":"JACC Clin Electrophysiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-025-01853-z","article-title":"Prescription pattern, glycemic control status, and predictors of poor glycemic control among diabetic patients with comorbid chronic kidney disease in Ethiopia: a facility-based cross-sectional study","volume":"25","author":"Muhammed OS","year":"2025","unstructured":"Muhammed OS, Hassen M, Mamusha S. Prescription pattern, glycemic control status, and predictors of poor glycemic control among diabetic patients with comorbid chronic kidney disease in Ethiopia: a facility-based cross-sectional study. BMC Endocr Disord. 2025, 25:28. 10.1186\/s12902-025-01853-z","journal-title":"BMC Endocr Disord"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2023.1816","article-title":"Initial combination therapy in type 2 diabetes","volume":"39","author":"Kim JY","year":"2024","unstructured":"Kim JY, Kim NH. Initial combination therapy in type 2 diabetes. Endocrinol Metab (Seoul). 2024, 39:23-32. 10.3803\/EnM.2023.1816","journal-title":"Endocrinol Metab (Seoul)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00414","article-title":"Dual-pathway antithrombotic therapy in patients with atrial fibrillation after percutaneous coronary intervention in stable coronary artery disease: a single-center, single-operator, retrospective cohort study","volume":"7","author":"Heger LA","year":"2020","unstructured":"Heger LA, Danzer M, Bode C, Hortmann M, Duerschmied D, Olivier CB, Moser M. Dual-pathway antithrombotic therapy in patients with atrial fibrillation after percutaneous coronary intervention in stable coronary artery disease: a single-center, single-operator, retrospective cohort study. Front Med (Lausanne). 2020, 7:414. 10.3389\/fmed.2020.00414","journal-title":"Front Med (Lausanne)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jscai.2022.100435","article-title":"Treatment strategies for coronary bifurcation lesions: complexity and risk","volume":"1","author":"Owen BM","year":"2022","unstructured":"Owen BM, Anderson HV. Treatment strategies for coronary bifurcation lesions: complexity and risk. J Soc Cardiovasc Angiogr Interv. 2022, 1:100435. 10.1016\/j.jscai.2022.100435","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-14-0144","article-title":"Validation of CHA\u2082DS\u2082-VASc and HAS-BLED scores in Japanese patients with nonvalvular atrial fibrillation: an analysis of the J-RHYTHM Registry","volume":"78","author":"Okumura K","year":"2014","unstructured":"Okumura K, Inoue H, Atarashi H, Yamashita T, Tomita H, Origasa H. Validation of CHA\u2082DS\u2082-VASc and HAS-BLED scores in Japanese patients with nonvalvular atrial fibrillation: an analysis of the J-RHYTHM Registry. Circ J. 2014, 78:1593-9. 10.1253\/circj.cj-14-0144","journal-title":"Circ J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/422467-balancing-bleeding-and-ischemic-risks-a-systematic-review-of-dual-versus-triple-therapy-after-percutaneous-coronary-intervention-in-patients-with-atrial-fibrillation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T15:04:22Z","timestamp":1765724662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/422467-balancing-bleeding-and-ischemic-risks-a-systematic-review-of-dual-versus-triple-therapy-after-percutaneous-coronary-intervention-in-patients-with-atrial-fibrillation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,14]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.99187","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,14]]}}}